Literature DB >> 26036805

In vitro-assessment of putative antiprogestin activities of phytochemicals and synthetic UV absorbers in human endometrial Ishikawa cells.

Qinan Yin1, Lara Fischer, Claudia Noethling, Wolfgang R Schaefer.   

Abstract

Critical steps of embryo implantation are controlled by progesterone. These processes can be interrupted by progesterone receptor (PR) antagonists, e.g. drugs used for abortion. Antiprogestin effects induced by natural compounds and environmental chemicals have been rarely addressed. In our in vitro study, we investigated putative antiprogestin activities of the plant compounds apigenin (API) and trans-ferulic acid (t-FA) as well as the UV absorbers octyl methoxycinnamate (OMC) and 4-methylbenzylidene camphor (4-MBC). They were compared with the selective progesterone receptor modulators (SPRMs) mifepristone (RU486) and ulipristal acetate (UPA) as well as the full PR-antagonist ZK137316. Effects of test compounds in combination with progesterone on the progesterone-sensitive target gene estrogen sulfotransferase (SULT1E1) were characterized by sigmoidal concentration-response curves obtained by RT-qPCR. The agonistic effect of progesterone on SULT1E1 mRNA levels was concentration-dependently antagonized by RU486, UPA and ZK137316 as well as, with lower potency, apigenin. t-FA, OMC and 4-MBC had no effect on SULT1E1 mRNA levels. We demonstrated that apigenin, although at higher concentrations, exerts a similar effect as the well-characterized SPRMs RU486 and UPA or the progesterone antagonist ZK137316 in this model. Our endometrium-specific Ishikawa cell assay is a useful complement to artificial transactivation assays for the identification of environmental substances with antiprogestin activities.

Entities:  

Keywords:  Endometrium; UV absorber; environmental antiprogestins; plant compounds; progesterone receptor

Mesh:

Substances:

Year:  2015        PMID: 26036805     DOI: 10.3109/09513590.2015.1047448

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  13 in total

1.  MiR-130a-5p contributed to the progression of endothelial cell injury by regulating FAS.

Authors:  Wei Wang; Wenbo Tang; Erbo Shan; Lei Zhang; Shiyuan Chen; Chaowen Yu; Yong Gao
Journal:  Eur J Histochem       Date:  2022-05-31       Impact factor: 1.966

2.  Effects of miR-132-3p on progress and epithelial mesenchymal transition of non-small cell lung cancer via regulating KLF7.

Authors:  Ning Wang; Ye Xu; Qingkui Guo; Chen Zhu; Wen Zhao; Wenliang Qian; Min Zheng
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

3.  Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis.

Authors:  Hui-Ling Xue; Ning Yu; Jing Wang; Wan-Jiao Hao; Ye Li; Mei-Yun Liu
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

4.  Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome.

Authors:  Jing Zhang; Qinqin Si; Jinqiong Li
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

5.  Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome.

Authors:  Zhihua Chen; Mengzhen Zhang; Yuhuan Qiao; Junjuan Yang
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

6.  MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.

Authors:  Ke Li; Conghu Yuan
Journal:  Int J Mol Med       Date:  2020-06-18       Impact factor: 4.101

7.  DUSP1 is involved in the progression of small cell carcinoma of the prostate.

Authors:  Yajing Zhang; Yan Zhang; Meng Chen; Ci Liu; Cheng Xiang
Journal:  Saudi J Biol Sci       Date:  2017-10-18       Impact factor: 4.219

8.  Upregulation of miR-582-5p regulates cell proliferation and apoptosis by targeting AKT3 in human endometrial carcinoma.

Authors:  Lingling Li; Li Ma
Journal:  Saudi J Biol Sci       Date:  2018-03-10       Impact factor: 4.219

9.  LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway.

Authors:  Hu Li; Zheng Zeng; Xiang Yang; Ye Chen; Lei He; Ting Wan
Journal:  Eur J Histochem       Date:  2020-11-10       Impact factor: 3.188

10.  MicroRNA-497-5p Functions as a Modulator of Apoptosis by Regulating Metadherin in Ovarian Cancer.

Authors:  Chunyan Liu; Anne Bordeaux; Stanka Hettich; Suhui Han
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.